Login / Signup

Once-daily roflumilast foam 0.3% for scalp and body psoriasis: A randomized, double-blind, vehicle-controlled phase 2b study.

Leon H KircikJavier Alonso-LlamazaresNeal BhatiaMichael BukhaloAlim R DevaniZoe D DraelosJanet DuBoisMelinda J GooderhamSteven E KempersEdward LainMark LeeAngela MooreDedee Frances MurrellKim A PappDavid M PariserRodney SinclairMatthew ZirwasPatrick BurnettRobert C HighamDavid KrupaDavid R Berk
Published in: The British journal of dermatology (2023)
NCT04128007.
Keyphrases
  • double blind
  • clinical trial
  • physical activity
  • placebo controlled
  • study protocol
  • phase iii